Bond Biosciences, Inc. — Form D/A

Bond Biosciences, Inc. of Parkville, MO, a company, filed a Form D amendment with the SEC on 2026-01-29. The offering totals $4.5M, of which $4.5M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2026-01-29
• Form: D/A
• Accession: 0001014108-26-000006
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $4.5M
• Amount sold: $4.5M
• Investors: 91
• Date of first sale: 2024-08-22
• Revenue range: Decline to Disclose
• SEC file number: 021-523360

Issuer

• Name: Bond Biosciences, Inc.
• CIK: 0001824224
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: 170 English Landing Drive SUITE 1201, Parkville, MO, 64152
• Phone: 650-804-2139

Officers, directors & promoters (16)

Other filings by this issuer (10)

More

• CIK 1824224 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search